We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein in Snake Venom Stops Bleeding

By Biotechdaily staff writers
Posted on 31 Mar 2006
A blood-clotting protein found in snake venom could rapidly stop excessive bleeding during vascular surgery and major trauma. More...


The protein responsible for the pro-coagulant or blood-clotting effect in the venom was found in the deadly coastal taipan snake and is called factor X. Factor X can stem blood flow in a matter of seconds. Mammals and snakes naturally produce a small amount of factor X in their livers, but snakes produce a more stable and faster acting form of the factor in their venom, which is the only source of factor X other than mammalian livers.

An experimental drug based on factor X is being evaluated for clinical trials by biopharmaceutical-development company QRxPharma (Toowong, Australia). Australia has 17 of the world's most deadly snakes, many of which have not been studied for therapeutic leads.

The protein was identified by Ph.D. researcher Liam St. Pierre, from the Queensland University of Technology School of Life Sciences (Brisbane, QLD, Australia), who studied the venom of eight of Australia's deadliest land snakes for their therapeutic potential.

Australian snakes literally have a two-pronged attack when they bite their prey. Firstly, venom injection causes massive blood clots instantaneously followed by paralysis as a result of neurotoxins which eventually immobilize and kill the victim,” said Dr. St. Pierre. They have developed the ability to deliver massive fatal doses of factor X to specifically target the systems of mammals.



Related Links:
Queensland University of Technology

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Automatic CLIA Analyzer
Shine i6000
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.